# Effect of Prebiotic Supplementation With and Without Physiotherapy on Pain and Pain Sensitivity in People with Knee Osteoarthritis

**Authors:** Afroditi Kouraki, Susan Franks, Amrita Vijay, Thomas Kurien, Moira A. Taylor, Stephanie L. Smith, Benjamin Smith, Anthony Kelly, Ana M. Valdes

PMC · DOI: 10.3390/nu18050714 · Nutrients · 2026-02-24

## TL;DR

This study found that inulin and physiotherapy both reduce knee osteoarthritis pain, but inulin also improves pain sensitivity and grip strength, possibly through gut-related mechanisms.

## Contribution

The study is the first to compare inulin and physiotherapy in knee OA, showing distinct benefits of inulin on pain sensitivity and grip strength linked to gut hormones.

## Key findings

- Inulin reduced pain and improved grip strength and pain sensitivity more than placebo.
- Physiotherapy improved mobility and balance but had higher dropout rates.
- Inulin increased SCFA butyrate and GLP-1, which correlated with improved grip strength.

## Abstract

Background: Emerging evidence links the gut microbiome to chronic pain processing. Inulin, a prebiotic fibre, modulates the gut microbiome, while physiotherapy-supported exercise (PSE) improves pain and function. We evaluated the effects of inulin supplementation with and without PSE on knee osteoarthritis (OA) pain. Methods: In a 2 × 2 factorial RCT, 117 community-dwelling adults with knee OA received 6 weeks of: (A) 20 g/day inulin, (B) digital PSE (Joint Academy™), (C) inulin +PSE, or (D) 10 g/day maltodextrin. Primary outcome: pain (Numerical Rating Scale). Secondary: 30 s sit-to-stand (30-CST), timed up and go (TUG), grip strength, and quantitative sensory testing. Serum short-chain fatty acids (SCFAs) and glucagon-like peptide-1 (GLP-1) were measured. The study was not powered to detect synergistic interaction. Results: A total of 117 participants (58.1% female; mean ± SD age = 67.5 ± 9.4 years; BMI = 29.5 ± 5.3 kg/m2; NRS = 3.96 ± 2.67) completed the trial. Pain improved with inulin (baseline-adjusted between-group mean difference (Δ) = −1.11 [95%CI −2.18, −0.04], p = 0.045) and PSE (Δ = −1.55 [95%CI −2.52, −0.58], p = 0.002) compared to placebo, with no synergistic effect. PSE improved TUG (p = 0.02) and 30-CST (p = 0.0004), while inulin improved grip strength (p = 0.002), pressure pain thresholds (p = 0.009) and temporal summation (p = 0.025) compared to placebo and had significantly lower dropout rates (3.6%) compared with PSE (21% p < 0.01). Only inulin increased SCFA butyrate (p = 0.0248) and GLP-1 (p = 0.0109), and higher GLP-1 was associated with improved grip strength, suggesting a gut–muscle link. Conclusions: Inulin and PSE each produced meaningful pain reductions. Only inulin improved pain sensitivity and grip strength, the latter paralleled by increased GLP-1, and had much higher rates of retention compared to PSE.

## Linked entities

- **Chemicals:** butyrate (PubChem CID 104775), glucagon-like peptide-1 (PubChem CID 16133831)

## Full-text entities

- **Genes:** GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}
- **Diseases:** chronic pain (MESH:D059350), Knee Osteoarthritis (MESH:D020370), OA) pain (MESH:D010146)
- **Chemicals:** butyrate (MESH:D002087), SCFA (MESH:D005232), Inulin (MESH:D007444), maltodextrin (MESH:C008315)
- **Species:** gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12986947/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12986947/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12986947/full.md

---
Source: https://tomesphere.com/paper/PMC12986947